ArticleBritish journal of pharmacology2005

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.

Ronald Esser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.